» Articles » PMID: 962865

Active-site Determinations on Forms of Mammalian Brain and Eel Acetylcholinesterase

Overview
Journal Biochem J
Specialty Biochemistry
Date 1976 Jul 1
PMID 962865
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Three forms of brain acetylcholinesterase were purified from bovine caudate-nucleus tissue and determined by calibrated gel filtration to have mol.wts. of approx. 120 000 (C), 230 000 (B) and 330 000 (A). [3H]Di-isopropyl phosphorofluoridate (isopropyl moiety labelled) was purified from commercial preparations and its concentration estimated by an enzyme-titration procedure. Brain acetylcholinesterase preparations and enzyme from eel electric tissue were allowed to react with [3H]di-isopropyl phosphorofluridate in phosphate buffer until enzyme activity was inhibited by 98%. Excess of [3H]di-isopropyl phosphorofluoridate that had not reacted was separated from the labelled enzyme protein by gel filtration, or by vacuum filtration or by extensive dialysis. The specificity of active-site labelling was confirmed by use of the enzyme reactivator, pyridine 2-aldoxime. The forms of brain acetylcholinesterase were calculted to contain approximately two (C) four (B) and six (A) active sites per molecule respectively. Acetylcholinesterase (mol.wt. 250 000) from electric-eel tissue was estimated to contain two active sites per molecule. Gradient-gel electrophoresis was used to confirm the estimation of molecular weights of brain acetylcholinesterase forms made by gel filtration. Under the conditions of electrophoresis acetylcholinesterase form A was stable, but form B was converted into a species of approx. 120 000 mol. wt. Similarly, form C of the brain enzyme was converted into a 60 000-mol.wt. form during electrophoresis. These results are in general accord with the suggestion that the multiple forms of brain acetylcholinesterase may be related to the aggregation of a single low-molecular-weight species.

Citing Articles

Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.

Zhan M, Hou S, Zhan C, Zheng F Biochem J. 2013; 457(1):197-206.

PMID: 24125115 PMC: 4372247. DOI: 10.1042/BJ20131100.


Active site gating and substrate specificity of butyrylcholinesterase and acetylcholinesterase: insights from molecular dynamics simulations.

Fang L, Pan Y, Muzyka J, Zhan C J Phys Chem B. 2011; 115(27):8797-805.

PMID: 21682268 PMC: 3135420. DOI: 10.1021/jp112030p.


Enzymological characteristic of the cholinesterase from the caudate nucleus of the Ladoga seal (Phoca hispida ladogensis) brain.

Rozengart E, Basova N Dokl Biochem Biophys. 2007; 416:260-3.

PMID: 18064827 DOI: 10.1134/s1607672907050092.


Characterization of a tetrameric G4 form of acetylcholinesterase from bovine brain: a comparison with the dimeric G2 form of the electric organ.

Fuentes M, Inestrosa N Mol Cell Biochem. 1988; 81(1):53-64.

PMID: 3173345 DOI: 10.1007/BF00225653.


The multiple forms of brain acetylcholinesterase. I. Micro-electrophoresis and topochemical analysis of the pattern.

Huther G, LUPPA H Histochemistry. 1977; 53(4):317-25.

PMID: 908654 DOI: 10.1007/BF00509248.


References
1.
ALDRIDGE W . Some properties of specific cholinesterase with particular reference to the mechanism of inhibition by diethyl p-nitrophenyl thiophosphate (E 605) and analogues. Biochem J. 1950; 46(4):451-60. PMC: 1275447. DOI: 10.1042/bj0460451. View

2.
Millar D, Grafius M . The subunit molecular weight of acetylcholinesterase. FEBS Lett. 1970; 12(1):61-64. DOI: 10.1016/0014-5793(70)80596-8. View

3.
Hollunger E, Niklasson B . The release and molecular state of mammalian brain acetylcholinesterase. J Neurochem. 1973; 20(3):821-36. DOI: 10.1111/j.1471-4159.1973.tb00042.x. View

4.
Froede H, Wilson I . On the subunit structure of acetylcholinesterase. Isr J Med Sci. 1970; 6(2):179-84. View

5.
Rosenberry T, Chang H, Chen Y . Purification of acetylcholinesterase by affinity chromatography and determination of active site stoichiometry. J Biol Chem. 1972; 247(5):1555-65. View